Metabolic syndrome and skin: psoriasis and beyond
- PMID: 23919003
- PMCID: PMC3726879
- DOI: 10.4103/0019-5154.113950
Metabolic syndrome and skin: psoriasis and beyond
Abstract
Metabolic syndrome (Met S) is a clustering of risk factors comprising of abdominal obesity, dyslipidemia, elevated blood pressure, and abnormal glucose tolerance. The prevalence of Met S has been increasing in the last few years throughout the world. Psoriasis has consistently been associated with Met S as well as its various components. However, the association is no longer limited to psoriasis alone. Various dermatological conditions such as lichen planus, androgenetic alopecia, systemic lupus erythematosus, skin tags, acanthosis nigricans, and even cutaneous malignancies have also been found to be associated with this syndrome. Though chronic inflammation is thought to be the bridging link, the role of oxidative stress and endocrine abnormalities has recently been proposed in bringing them together.
Keywords: Androgenetic alopecia; cardiovascular risk; chronic inflammation; metabolic syndrome; psoriasis.
Conflict of interest statement
References
-
- Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–72. - PubMed
-
- Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16. - PubMed
-
- Third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–421. - PubMed
-
- Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study. Br J Dermatol. 2007;157:68–73. - PubMed
-
- Wong ND. Metabolic syndrome: Cardiovascular risk assessment and management. Am J Cardiovasc Drugs. 2007;7:259–72. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous